Replies to post #220930 on Biotech Values

[DewDiligence]

Folksy shareholder letter from CGIX CEO—as noted in #msg-80595791 and #msg-71344011, I consider these red flags:

https://globenewswire.com/news-release/2018/10/16/1621871/0/en/Cancer-Genetics-Issues-Letter-to-Shareholders.html

[DewDiligence]

CGIX terminates proposed merger with NovellusDx due to “difficulties…in advancing the merger process”:

https://finance.yahoo.com/news/cancer-genetics-terminates-proposed-merger-130000550.html